See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Trade War
Donald Trump
Social Media
Natural Disasters
Senate
Artificial Intelligence
Trade
Stock Markets
Golf
European Union
Published • loading... • Updated

Machine learning in preclinical drug discovery

Summary by Nature
Drug-discovery and drug-development endeavors are laborious, costly and time consuming. These programs can take upward of 12 years and cost US $2.5 billion, with a failure rate of more than 90%. Machine learning (ML) presents an opportunity to improve the drug-discovery process. Indeed, with the growing abundance of public and private large-scale biological and chemical datasets, ML techniques are becoming well positioned as useful tools that ca…

4 Articles

All
Left
Center
2
Right
TechCrunchTechCrunch
Center

Google plans to release new 'open' AI models for drug discovery

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models for drug discovery called

·United States
Read Full Article
NatureNature
Center

Machine learning in preclinical drug discovery

Drug-discovery and drug-development endeavors are laborious, costly and time consuming. These programs can take upward of 12 years and cost US $2.5 billion, with a failure rate of more than 90%. Machine learning (ML) presents an opportunity to improve the drug-discovery process. Indeed, with the growing abundance of public and private large-scale biological and chemical datasets, ML techniques are becoming well positioned as useful tools that ca…

·United Kingdom
Read Full Article
Drug Discovery and DevelopmentDrug Discovery and Development

Proscia is using AI embeddings in drug discovery in pathology

Picture this: A lung cancer drug candidate was headed for abandonment until AI-powered pathology analysis identified which patients would benefit from it. Using machine learning and digital pathology, the two sponsors backing the candidate built an algorithm capable of distinguishing responders from non-responders to the compound they were developing. “Without that AI model and digital… The post How Proscia is using AI embeddings to transform dr…

Read Full Article
Labiotech.euLabiotech.eu

How biotechs are using AI to rescue failed drugs

Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs. The post How biotechs are using AI to rescue failed drugs appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear cr…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Labiotech.eu broke the news in on Monday, March 17, 2025.
Sources are mostly out of (0)

Similar News Topics

Google

Google

Artificial Intelligence

Artificial Intelligence

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal